Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 21Recruiting 4Unknown 3Terminated 3Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Gynecologic 3Head & Neck 2Genitourinary 2Thoracic 1Plasma cell 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Neoplasm Metastasis 1Kidney Calculi 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 9Magnetic Resonance Spectroscopy 9pembrolizumab 8toripalimab 7darolutamide 7Nivolumab 7Drug Therapy 7Docetaxel 7Radiosurgery 6Cystectomy 6enzalutamide 5apalutamide 5abiraterone 5Mitomycin 5Cisplatin 5Abiraterone Acetate 5disitamab vedotin 4Pluvicto 4Cyclophosphamide 4Axitinib 4tislelizumab 3fludarabine 3enfortumab vedotin 3cemiplimab 3cabozantinib 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Therapeutics × Genitourinary × Clear all
NCT07555756 2026-04-29

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

First Affiliated Hospital of Guangxi Medical University

Phase NA Not yet recruiting
1,080 enrolled
Genitourinary

Urinary Bladder Neoplasms, Kidney Calculi, Prostatic Hyperplasia

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

University of Chicago

Phase 4 Not yet recruiting
80 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡